Seeing Is Believing
Currently out of the existing stock ratings of Gil Blum, 512 are a BUY (98.46%), 5 are a HOLD (0.96%), 3 are a SELL (0.58%).
Analyst Gil Blum, currently employed at NEEDHAM, carries an average stock price target met ratio of 28.32% that have a potential upside of 67.04% achieved within 142 days.
Gil Blum’s has documented 957 price targets and ratings displayed on 32 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CELC, Celcuity LLC.
Analyst best performing recommendations are on IMAB (I-MAB).
The best stock recommendation documented was for CELC (CELCUITY LLC) at 6/30/2025. The price target of $29 was fulfilled within 28 days with a profit of $15.65 (117.23%) receiving and performance score of 41.87.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
$24
$22.6 (1614.29%)
$60
2 years 9 months 14 days ago
(18-Dec-2023)
0/5 (0%)
$24 (0.00%)
$2
$0.6 (42.86%)
$36
3 years 2 months 19 days ago
(13-Jul-2023)
0/3 (0%)
$2 (0.00%)
$2
$0.6 (42.86%)
$14
3 years 2 months 20 days ago
(12-Jul-2023)
0/4 (0%)
$2 (0.00%)
$6
$4.6 (328.57%)
$6
3 years 6 months 8 days ago
(24-Mar-2023)
0/5 (0%)
$6 (0.00%)
Hold Since 08-Dec-2022
$4
3 years 9 months 24 days ago
(08-Dec-2022)
0/3 (0%)
$4 (0.00%)
Which stock is Gil Blum most bullish on?
Which stock is Gil Blum most reserved on?
What Year was the first public recommendation made by Gil Blum?